Altered gut microbiome composition by appendectomy contributes to colorectal cancerOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether appendectomy raises colorectal cancer (CRC) risk by disturbing the gut microbiome. The researchers combined a population-based longitudinal analysis with shotgun metagenomic sequencing of fecal samples to characterize microbial changes after appendectomy. They then tested whether appendectomy directly promotes colorectal tumorigenesis using a mouse model, and examined microbial network structure to identify which bacteria most strongly organize the post-appendectomy community.
Who was studied?
Cohort 1 was a large population-based longitudinal group of 129,155 individuals followed for up to 20 years to assess CRC incidence after appendectomy. Cohort 2 consisted of 314 people whose fecal samples underwent shotgun metagenomic sequencing to compare gut microbial composition between appendectomy subjects and controls. The mouse tumorigenesis experiments used an animal model to test causality, as described in the abstract.
What were the most important findings?
Appendectomy was associated with a 73.0 percent increase in CRC risk over 20 years of follow-up (adjusted SHR 1.73, 95% CI 1.49-2.01, P < 0.001). Metagenomic sequencing showed appendectomy subjects had enrichment of seven CRC-promoting bacteria, including Bacteroides fragilis (B. fragilis), Bacteroides vulgatus, Veillonella dispar, and several Prevotella species, alongside depletion of five beneficial commensals such as Collinsella aerofaciens and multiple Blautia species. Microbial network analysis revealed stronger correlations among the enriched, oncogenic-pathway-associated bacteria in appendectomy subjects, with B. fragilis occupying the central, most connected position in this network. Mouse experiments confirmed that appendectomy promoted colorectal tumorigenesis through its effects on the gut microbiome.
What are the greatest implications of this study?
These findings suggest appendectomy is not a neutral procedure with respect to long-term colorectal cancer risk, and that this risk may be mediated by a shift toward a CRC-promoting, B. fragilis-centered microbial network. Because B. fragilis functioned as the hub of this altered network, it may represent a key node for monitoring or intervention in post-appendectomy patients. The mouse data support a causal, not merely correlational, link between appendectomy-driven dysbiosis and tumorigenesis, strengthening the rationale for microbiome surveillance in this population.